ShK and its analogues significantly reduce disease severity in several animal models of TEM lymphocyte-related diseases including delayed-type hypersensitivity, chronic relapsing-remitting experimental autoimmune encephalomyelitis, pristane-induced arthritis and asthma via blockade of Kv1.3 channels in TEM cells6–9. This evidence concerns the gene KCNA3 and asthma.